✦ LIBER ✦

Risk factors predictive of anemia development during telaprevir plus peginterferon/ribavirin therapy in treatment-experienced patients

✍ Scribed by Zeuzem, Stefan; DeMasi, Ralph; Baldini, Alessandra; Coate, Bruce; Luo, Donghan; Mrus, Joseph; Witek, James

Book ID: 122872728
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 680 KB
Volume: 60
Category: Article
ISSN: 0168-8278
DOI: 10.1016/j.jhep.2014.01.013

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

1174 DEEP SEQUENCING SCREENING FOR TELAP

1174 DEEP SEQUENCING SCREENING FOR TELAPREVIR-RESISTANT VIRAL VARIANTS IN PREVIOUS NULL RESPONDERS FAILS TO IDENTIFY THOSE PATIENTS AT RISK OF FAILING TELAPREVIR PLUS PEGINTERFERON/RIBAVIRIN THERAPY

✍ De Meyer, S.; Thys, K.; Dierynck, I.; Ghys, A.; Aerssens, J.; Picchio, G. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Pretreatment prediction of virological r

Pretreatment prediction of virological response to peginterferon plus ribavirin therapy in chronic hepatitis C patients using viral and host factors

✍ Haruaki Shirakawa; Akihiro Matsumoto; Satoru Joshita; Michiharu Komatsu; Naoki T 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 181 KB 👁 1 views

COST-EFFECTIVENESS OF TELAPREVIR COMBINA

COST-EFFECTIVENESS OF TELAPREVIR COMBINATION THERAPY COMPARED TO PEGINTERFERON WITH RIBAVIRIN ALONE FOR NAIVE AND TREATMENT EXPERIENCED PATIENTS WITH GENOTYPE 1 CHRONIC HEPATITIS C IN POLAND

✍ Kaczor, M.P.; Wójcik, R.; Pawlik, D.; Skrzekowska-Baran, I.; Tronczynski, K. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB

1167 PRE-TREATMENT IP-10 LEVELS AND IL28

1167 PRE-TREATMENT IP-10 LEVELS AND IL28B GENOTYPE IN PREDICTION OF SVR IN PRIOR TREATMENT-EXPERIENCED GENOTYPE 1 HCV PATIENTS TREATED WITH TELAPREVIR/PEGINTERFERON/RIBAVIRIN IN THE REALIZE STUDY

✍ Vijgen, L.; Talloen, W.; Scholliers, A.; Johansson, S.; Tuefferd, M.; De Meyer, 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Pretreatment prediction of virological r

Pretreatment prediction of virological response to peginterferon plus ribavirin therapy in patients with chronic hepatitis C, using viral and host factors: Some concerns

✍ Chia-Yen Dai; Wan-Long Chuang; Jee-Fu Huang; Ming-Yen Hsieh; Ming-Lung Yu 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 48 KB 👁 2 views

We read with great interest the article published in a recent issue of HEPATOLOGY. 1 Shirakawa et al. enrolled 120 patients with chronic hepatitis C (CHC) infected with genotype 1 hepatitis C virus (HCV-1) and high baseline viral loads (HVL), defined by HCV RNA levels Ն 10 5 international units (IU)

Sa1041 Triple Therapy Under Real Life Co

Sa1041 Triple Therapy Under Real Life Conditions: Telaprevir (TVR) and Boceprevir (BOC) in Combination With Peginterferon-Alfa-2A Plus Ribavirin (P/R) in Treatment Experienced Patients Infected With Chronic Hepatitis C, Genotype 1. the PAN Study

✍ Moog, Gero; Mauss, Stefan; Hueppe, Dietrich; Spengler, Ulrich; Schott, Eckart; E 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 285 KB